Sign in
Welcome! Log into your account
Forgot your password? Get helpPrivacy PolicyPassword recovery
Recover your password
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology NewsHomeTopicsBioprocessingBlueprint to Fill the Manufacturing Talent Gap
Operator at the pilot plant at our Augusta BioFacility. [Manus]
As biopharmaceutical companies expand facilities and reshore some manufacturing operations, the industry faces a shortfall of trained workers for its manufacturing facilities. While the Bureau of Labor Statistics recentlypredictedsome 19,000 jobs would be created, PhRMA last year predicted the creation of 100,000 new jobs. Both predictions leave a gap between those jobs and the trained workforce.
To close the gap, Manus, a next-gen industrial biotechnology company, and BioMADE have developed an apprenticeship program that can become a blueprint for other companies to develop their own training. “The program can be scaled so development for other [companies] can be faster, down the road,” says Maren Wehrs, PhD, program manager at BioMADE.
“We are trying to build a fairly comprehensive training program that spans fermentation operations as well as downstream purification,” Christine Santos, PhD, CTO, Manus, tellsGEN.
Focus: Hands-on learning
“It’s focused on hands-on experiential learning,” Santos continues, “with an extensive curriculum that will include deep dives on the practical aspects of running the equipment, such as so sterilization, safety, contamination control, process monitoring, and analytics. It will also delve into some of the technical aspects, like scale-up principles, as well as decision-making, problem-solving, teamwork, and communications.”
The work occurs at a Manus pilot facility in Augusta, GA. The first cohort starts in July and completes at year’s end, with another cohort beginning in January. After 18 months, “We hope to have a blueprint for an apprenticeship program that could be deployed at any other facility,” Santos says, including new BioMADE pilot facilities or those of other companies.
“We would offer access to the curriculum and the blueprint for [others] to deploy. We’ve spent the past few months formalizing the curriculum,” Santos says. It was developed with input from the University of Georgia, but apprentices needn’t be enrolled in a university program to participate.
Manus’ interest in apprenticeships stems from its 2018 acquisition of a decommissioned NutraSweet manufacturing facility in Augusta for its cell factories and bioprocesses.
“We had the task of recommissioning the facility and rebuilding the workforce to operate it,” Santos recounts. “We were able to rehire some of the NutraSweet employees [and regain their institutional knowledge], but to build out further, we had a huge challenge finding workers who were trained for biomanufacturing operations. We had to invest in a lot of hands-on training.”
This program is one of a few offered directly by a biomanufacturer. More commonly, companies participate in workforce training consortia to develop potential manufacturing workers.
InsightsBiopharmaceuticalsDownstream processFermentationTraining supportAlso of Interest
Manus and UT Austin Advance Biomanufacturing Product Recovery Through BioMADE ProgramTop 10 Contract Development and Manufacturing Organizations 2026Purifying Complex Therapeutics Requires Fresh ApproachesManaging Misbehaving mAbs with Advanced Purification StrategiesADCs, mAbs, CAR Ts: One Bioluminescent Platform Measures Them AllAI Drug Discovery Hits a New Bottleneck: Experimental ValidationRelated Media
Reporting Live from JPM 2026: Alex Philippidis and Jonathan Grinstein, PhDBoston and Bioprocessing: GEN Reports Live from the First Day at BPIEmerging Markets Collaborate to Succeed in Post-Pandemic WorldResins Address Downstream Purification ConcernsImproving Protein Therapeutic Production is a Key Goal of Biopharma 4.0Biomanufacturing’s 10-Year Plan for the FutureTop 5ResourcesRecommended For YouPodcast
Touching Base
Touching Base is the dynamic podcast series from the editors ofGEN. Each episode features a rotating case of senior editors—including John Sterling, Kevin Davies, Julianna LeMieux, Alex Phillippidis, Uduak Thomas, Corinna Singleman, and Fay Lin—who delve into emerging stories, exchange ideas, and debate the latest trends in biotech. Additionally, they talk to some of the leading voices in the industry about what's now and next.Start listening today!
Stay up to date with the lasted episodes of Touching Base bysubscribing to theGENPodcast Newsletter
Copyright © 2026 Sage Publications or its affiliates, licensors, or contributors. All rights reserved, including those for text and data mining and training of large language models, artificial intelligence technologies, or similar technologies.
MORE STORIES
